Amili Pte. Ltd. is engaged in the manufacture of biological products and preparations for human use, specializing in microbiome science. The company operates Southeast Asia’s first and only gut microbiome transplant bank and maintains the world’s largest multi-ethnic Asian gut microbiome database. Its services include personalized probiotics, gut health test kits, and microbiome-based therapeutics and diagnostics. It was incorporated in 2019 and is based in Singapore, Singapore.
Headquarters
89 Science Park Drive #03-09
The Rutherford, Lobby C Science Park 1
Singapore; Singapore;
Postal Code: 118261
Contact Details: Purchase the Amili Pte. Ltd. report to view the information.
Website: https://www.amili.asia/
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service